Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Target

adaptive immunity

1 abstract

Abstract
The tumor immune profile of bladder cancer (BC) with HER2 over-expression and the investigation into RC48-ADC versus BCG in high-risk non-muscle invasive BC with HER2 over-expression.
Org: Department of Urology, Jinling Hospital, Clinical School of Medical College, Nanjing University, Nanjing, China, Institute of Urology, West China Hospital, Sichuan University, Chengdu Origen Biotechnology,